KR900001214B1 - 1-아릴옥시-2,3,4,5-테트라하이드로-3-벤즈아제핀의 제조방법 - Google Patents

1-아릴옥시-2,3,4,5-테트라하이드로-3-벤즈아제핀의 제조방법 Download PDF

Info

Publication number
KR900001214B1
KR900001214B1 KR1019830002597A KR830002597A KR900001214B1 KR 900001214 B1 KR900001214 B1 KR 900001214B1 KR 1019830002597 A KR1019830002597 A KR 1019830002597A KR 830002597 A KR830002597 A KR 830002597A KR 900001214 B1 KR900001214 B1 KR 900001214B1
Authority
KR
South Korea
Prior art keywords
compound
tetrahydro
formula
benzazine
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019830002597A
Other languages
English (en)
Korean (ko)
Other versions
KR840005103A (ko
Inventor
챨레스 에플란드 리챠드
토마스 클레인 조세프
데이비스 라리
Original Assignee
훽스트-로우쎌 파마슈티컬 인코포레이티드
마크 이.로가트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 훽스트-로우쎌 파마슈티컬 인코포레이티드, 마크 이.로가트 filed Critical 훽스트-로우쎌 파마슈티컬 인코포레이티드
Publication of KR840005103A publication Critical patent/KR840005103A/ko
Application granted granted Critical
Publication of KR900001214B1 publication Critical patent/KR900001214B1/ko
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
KR1019830002597A 1982-06-14 1983-06-11 1-아릴옥시-2,3,4,5-테트라하이드로-3-벤즈아제핀의 제조방법 Expired KR900001214B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US387,916 1982-06-14
US06/387,916 US4988690A (en) 1982-06-14 1982-06-14 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines and anti-depressant use thereof
US389,916 1989-08-07

Publications (2)

Publication Number Publication Date
KR840005103A KR840005103A (ko) 1984-11-03
KR900001214B1 true KR900001214B1 (ko) 1990-02-28

Family

ID=23531838

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830002597A Expired KR900001214B1 (ko) 1982-06-14 1983-06-11 1-아릴옥시-2,3,4,5-테트라하이드로-3-벤즈아제핀의 제조방법

Country Status (17)

Country Link
US (1) US4988690A (https=)
EP (1) EP0096838B1 (https=)
JP (1) JPS595165A (https=)
KR (1) KR900001214B1 (https=)
AT (1) ATE26263T1 (https=)
AU (1) AU570920B2 (https=)
CA (1) CA1214460A (https=)
DE (1) DE3370621D1 (https=)
DK (1) DK270983A (https=)
ES (1) ES523191A0 (https=)
FI (1) FI78473C (https=)
GR (1) GR78291B (https=)
HU (1) HU190902B (https=)
IE (1) IE55404B1 (https=)
IL (1) IL68964A (https=)
PT (1) PT76864B (https=)
ZA (1) ZA834309B (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA882080B (en) * 1987-03-27 1989-04-26 Schering Corp Substituted benzazepines,their preparation and pharmaceutical compositions containing them
US5015639A (en) * 1987-03-27 1991-05-14 Schering Corporation Substituted benzazepines, their preparation and pharmaceutical compositions containing them
CA1327795C (en) * 1987-08-14 1994-03-15 Jules Freedman Antidepressants which are aryloxy inadanamines
US5202319A (en) * 1991-09-23 1993-04-13 Hoechst-Roussel Pharmaceuticals Inc. Substituted 3-amino-2,3,4,5-tetrahydro-1-aryloxy-3-benzazepines
US5639482A (en) * 1993-11-10 1997-06-17 Crary; Ely J. Composition for control and prevention of diabetic retinopathy
AU2002228725A1 (en) * 2000-11-30 2002-06-11 Advanced Research And Technology Institute, Inc. Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
CN1805938B (zh) * 2003-06-17 2010-06-16 艾尼纳制药公司 用于治疗5ht2c受体相关疾病的苯并氮杂卓衍生物
HUE028976T2 (en) * 2003-06-17 2017-02-28 Arena Pharm Inc 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
WO2005042490A1 (en) * 2003-10-22 2005-05-12 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
WO2005042491A1 (en) * 2003-10-22 2005-05-12 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
SI1838677T1 (sl) 2004-12-21 2010-01-29 Arena Pharm Inc Kristalne oblike (R)-8-kloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazepin hidroklorida
SG158168A1 (en) 2004-12-23 2010-01-29 Arena Pharm Inc 5ht2c receptor modulator compositions and methods of use
EP2471779A1 (en) 2006-04-03 2012-07-04 Arena Pharmaceuticals, Inc. Process for the resolution of a mixture of (R)- and (S)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
US8299241B2 (en) * 2006-12-05 2012-10-30 Arena Pharmaceuticals, Inc. Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof
CA2685861A1 (en) 2007-05-10 2008-11-20 Amr Technology, Inc. Aryloxy-and heteroaryloxy-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
CN102015591B (zh) 2008-03-04 2014-01-29 艾尼纳制药公司 制备与5-ht2c激动剂(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓相关的中间体的方法
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
KR20130112848A (ko) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. 5-ht2c 수용체 아고니스트의 제조 방법
JP2013536859A (ja) 2010-09-01 2013-09-26 アリーナ ファーマシューティカルズ, インコーポレイテッド 5−ht2cアゴニストの非吸湿性塩
KR20140091458A (ko) 2010-09-01 2014-07-21 아레나 파마슈티칼스, 인크. 신장 손상을 갖는 개체에 대한 로카세린의 투여
EP3485878A1 (en) 2010-09-01 2019-05-22 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-ht2c agonists useful for weight management
KR20130138770A (ko) 2010-09-01 2013-12-19 아레나 파마슈티칼스, 인크. 광학적으로 활성 산을 갖는 로르카세린의 염
WO2014058441A1 (en) 2012-10-09 2014-04-17 Arena Pharmaceuticals, Inc. Method of weight management

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5233687A (en) * 1975-09-11 1977-03-14 Shionogi & Co Ltd Process for preparation of 1,5-dihydro-2h-1,4-benzodiazepine-2-on deri vatives
JPS5481290A (en) * 1977-11-17 1979-06-28 Smithkline Corp Benzazepin compound

Also Published As

Publication number Publication date
ES8503666A1 (es) 1985-03-01
EP0096838A1 (en) 1983-12-28
CA1214460A (en) 1986-11-25
PT76864B (en) 1986-02-27
FI78473B (fi) 1989-04-28
IL68964A0 (en) 1983-10-31
JPS595165A (ja) 1984-01-12
AU570920B2 (en) 1988-03-31
PT76864A (en) 1983-07-01
ZA834309B (en) 1984-03-28
FI832092L (fi) 1983-12-15
DK270983A (da) 1983-12-15
JPH0365342B2 (https=) 1991-10-11
FI832092A0 (fi) 1983-06-10
EP0096838B1 (en) 1987-04-01
IE55404B1 (en) 1990-09-12
ES523191A0 (es) 1985-03-01
KR840005103A (ko) 1984-11-03
FI78473C (fi) 1989-08-10
ATE26263T1 (de) 1987-04-15
IE831384L (en) 1983-12-14
AU1576483A (en) 1983-12-22
US4988690A (en) 1991-01-29
DK270983D0 (da) 1983-06-13
IL68964A (en) 1988-03-31
HU190902B (en) 1986-12-28
GR78291B (https=) 1984-09-26
DE3370621D1 (en) 1987-05-07

Similar Documents

Publication Publication Date Title
KR900001214B1 (ko) 1-아릴옥시-2,3,4,5-테트라하이드로-3-벤즈아제핀의 제조방법
RU2079493C1 (ru) Способ получения 4-амино-2-(4-метилпиперазин-1-ил)-5-(2,3,5-трихлорфенил) пиримидина или его кислой аддитивной соли
KR880000204B1 (ko) 설포닐 우레아 유도체
KR910000251B1 (ko) 비시클로 치환된 페닐아세토니트릴 유도체
FR2501690A1 (fr) Derives heterocycliques du type 1,2,4-triazole, leur preparation et leur application pharmacologique
LU85442A1 (fr) Agents antidepression a base de 1,2,4-triazol-3-one
JPH01139565A (ja) フェネタノールアミン誘導体
JPH0224821B2 (https=)
KR890001998B1 (ko) 페닐알킬아미노에틸살리실아미드의 제조방법
US6503909B1 (en) Pyrazine compounds
US20050176763A1 (en) 3-Thia-4-arylquinolin-2-one potassium channel modulators
US6465461B1 (en) Triazine compounds for treatment of CNS disorders
RU2161613C2 (ru) Арилалкилтиадиазиноны, способ их получения, фармацевтическая композиция
US4198424A (en) Substituted 1-phenyl-2-pyrrolidin-2-yl-ethanols, their synthesis, their use and their compositions
FR2461699A1 (fr) Nouveaux derives de type methylene-3 azetidine utiles comme medicaments et compositions therapeutiques les contenant
US3629266A (en) (phenyl piperidino alkyl)3 4-dihydrocarbostyrils
JPH02300184A (ja) インドール誘導体
JPS648621B2 (https=)
JPS6334865B2 (https=)
US4857536A (en) Antihistaminic benzimidazole derivatives
US4616011A (en) Novel indole derivatives and pharmaceutical compositions containing same
EP0113910A1 (en) Isocarbostyril derivatives, processes for their preparation and pharmaceutical compositions containing them
GB1579352A (en) 3,5-disubstituted-1h-1,2,4-triazoles
EP1242381A2 (fr) Derives de 2-phenyl-quinoleine et leur utilisation en tant qu'agent contractant des muscles lisses
US4997833A (en) Aryloxy-aminoalkanes, and antihypertensive use thereof

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19830611

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19870925

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19830611

Comment text: Patent Application

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19900129

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19900528

NORF Unpaid initial registration fee
PC1904 Unpaid initial registration fee